CD24 expression was significantly correlated with the presence of LN metastasis (P < 0.001), higher pN type (regional lymph nodes) (P = 0.006) and more advanced pathological stage (P = 0.020), suggesting that high CD24 expression is associated with more aggressive breast cancer (Table 1). Here, CD24 is linked to breast carcinoma.